DeepMed Research

Skane University Hospital

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: Private

Employees: -

Market Cap: -

Website: http://vard.skane.se

Clinical Trials

Lactobacillus Plantarum 299v in Colon Surgery

Not Applicable

Completed

Conditions: Bacterial Translocation
Inflammation
Cell Proliferation

Interventions: Dietary Supplement: Lactobacillus plantarum 299v in oatmeal drink
Dietary Supplement: Oatmeal drink

First Posted Date: 2008-06-11

Last Posted Date: 2008-06-11

Lead Sponsor: Skane University Hospital

Target Recruit Count: 72

Registration Number: NCT00695461

Locations: 🇸🇪
Dept of Surgery, Malmö University Hospital, Malmö, Sweden

Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes

Phase 4

Completed

Conditions: Type 2 Diabetes
Secondary Drug Failure

Interventions: Drug: pioglitazone
Drug: insulin glargine

First Posted Date: 2008-02-07

Last Posted Date: 2008-02-07

Lead Sponsor: Skane University Hospital

Target Recruit Count: 36

Registration Number: NCT00609856

Locations: 🇸🇪
Malmö University Hospital, Malmö, Sweden

The Von Willebrand Disease (VWD) International Prophylaxis Study

Completed

Conditions: Von Willebrand Disease

Interventions: Drug: VWF/FVIII products

First Posted Date: 2007-11-14

Last Posted Date: 2017-10-06

Lead Sponsor: Skane University Hospital

Target Recruit Count: 105

Registration Number: NCT00557908

Locations: 🇸🇪
Skåne University Hospital, Malmö, Sweden
🇺🇸
Rho, Inc., Chapel Hill, North Carolina, United States
🇺🇸
BloodCenter of Wisconsin, Milwaukee, Wisconsin, United States

Vacuum Assisted Wound Closure (VAWC) and Mesh Mediated Fascial Traction

Not Applicable

Completed

Conditions: Fascial Closure
Open Abdomen

Interventions: Procedure: VAWC and mesh mediated fascial traction

First Posted Date: 2007-07-02

Last Posted Date: 2017-12-29

Lead Sponsor: Skane University Hospital

Target Recruit Count: 111

Registration Number: NCT00494793

Locations: 🇸🇪
Department of Surgery, Falu Hospital, Falun, Sweden
🇸🇪
Department of Surgery, Malmö University Hospital, Malmö, Sweden
🇸🇪
Department of Surgery, Gävle Hospital, Gävle, Sweden

and more 2 locations

Randomized Controlled Trial of Human Papillomavirus Testing in Primary Cervical Cancer Screening

Not Applicable

Completed

Conditions: Cervical Cancer
Cervical Intraepithelial Neoplasia

First Posted Date: 2007-05-28

Last Posted Date: 2007-05-28

Lead Sponsor: Skane University Hospital

Target Recruit Count: 12527

Registration Number: NCT00479375

Locations: 🇸🇪
Malmo University Hospital, Malmo, Sweden

ProLOVE - Prospective Randomized Study of Midline Incisional Hernia Treatment

Completed

Conditions: HERNIA, VENTRAL

First Posted Date: 2007-05-11

Last Posted Date: 2013-04-24

Lead Sponsor: Skane University Hospital

Target Recruit Count: 157

Registration Number: NCT00472537

Locations: 🇸🇪
Lund University Hospital, Department of Surgery, Lund, Sweden
🇸🇪
Malmö University Hospital, Department of Surgery, Malmö, Sweden
🇸🇪
Helsingborg Hospital, Department of Surgery, Helsingborg, Sweden

and more 4 locations

Atorvastatin in Moderate Active Crohns Disease

Phase 2

Completed

Conditions: Crohns Disease

First Posted Date: 2007-03-30

Last Posted Date: 2007-10-22

Lead Sponsor: Skane University Hospital

Target Recruit Count: 12

Registration Number: NCT00454545

Locations: 🇸🇪
Department of Medicine, Division of Gastroenterology and Hepatology, Malmö, Sweden

The Malmö International Brother Study (MIBS)

Completed

Conditions: Hemophilia A With Inhibitors

First Posted Date: 2005-10-04

Last Posted Date: 2005-10-04

Lead Sponsor: Skane University Hospital

Registration Number: NCT00231751

Locations: 🇸🇪
Malmö University Hospital, Malmö, Sweden

Hemophilia Inhibitor Genetics Study (HIGS)

Completed

Conditions: Hemophilia A With Inhibitor

Interventions: Procedure: Blood draw

First Posted Date: 2005-09-14

Last Posted Date: 2014-03-26

Lead Sponsor: Skane University Hospital

Target Recruit Count: 1137

Registration Number: NCT00166387

Locations: 🇸🇪
Malmo University Hospital, Malmo, Sweden

The FEIBA NovoSeven Comparative Study

Not Applicable

Completed

Conditions: Severe Hemophilia A With an Inhibitor

First Posted Date: 2005-09-14

Last Posted Date: 2007-04-19

Lead Sponsor: Skane University Hospital

Target Recruit Count: 60

Registration Number: NCT00166309

Locations: 🇸🇪
Malmo University Hospital, Malmo, Sweden

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy